As biologics gain greater prominence, protein engineers adjust their foci to new indications, improved targeting, new formats, and products that are truly differentiated relative to competitors. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving qualities, enhancing efficacy, and fine-tuning manufacturing.

Conferences Include:

January 9-10

Recombinant Protein Therapeutics

January 10-11

Enhancing Antibody Binding and Specificity

January 12-13

Emerging Technologies for Antibody Discovery